TMDX R&D to Revenue
Transmedics Group Inc · R&D to Revenue
TMDX R&D to Revenue
Latest reported16.65%period ending
TMDX Quarterly R&D/Revenue (219.64% → 16.65%)
Latest values, visible window
High-resolution chart · PNG
TMDX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 16.653% | |
| 14.3038% | |
| 12.8766% | |
| 10.6103% | |
| 10.1252% | |
| 11.9551% | |
| 13.5368% | |
| 13.1168% | |
| 12.1237% | |
| 11.7501% | |
| 13.2567% | |
| 57.7209% | |
| 15.8029% | |
| 14.1286% | |
| 18.3458% | |
| 26.5078% | |
| 32.7177% | |
| 47.4433% | |
| 65.3082% | |
| 96.1453% | |
| 77.0408% | |
| 64.2563% | |
| 59.6303% | |
| 58.5954% | |
| 115.0988% | |
| 82.6693% | |
| 103.3845% | |
| 68.5496% | |
| 84.4864% | |
| 83.0197% | |
| 98.3634% | |
| 81.0102% | |
| 117.7702% | |
| 137.5546% | |
| 161.5385% | |
| 182.2175% | |
| 187.8584% | |
| 219.639% |